Zelapar

In the US, Zelapar (selegiline systemic) is a member of the following drug classes: dopaminergic antiparkinsonism agents, monoamine oxidase inhibitors and is used to treat ADHD, Depression and Parkinson's Disease.

US matches:

• Zelapar


• Zelapar Orally Disintegrating Tablets

UK matches:

• Zelapar
• Zelapar (Cephalon Limited) (SPC)

Ingredient matches for Zelapar

Selegiline

Selegiline hydrochloride (a derivative of Selegiline) is reported as an ingredient of Zelapar in the following countries:

• Argentina


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.